Uncleared Margin Rules transition from Multi-Phase Implementation to a focus on Optimal Margin Management

By Chris Walsh, CEO Acadia

Having entered the sixth phase of UMR, the OTC derivatives industry is now mainstreaming UMR compliance and starting to move towards optimizing performance under the broader regulatory framework that UMR is now part of.  To achieve optimal performance, market participants are challenged to create a more holistic approach towards risk, margin, and collateral.  This drive for performance - and the holistic approach on which it depends is changing how the industry is working and is a fundamental driver of what Acadia has started to refer to as Optimal Margin Management (“OMM”).

This whitepaper covers:

• Why is OMM required?
• IM Workflow
• Integrated Margining
• Optimal Margin Management Framework

Fill out the form below to download the whole paper and find out more.